Showing results (1-10 of 1,022) with videos related to
Sort By:
Pageof 103
Thrombosis and Haemostasis|January 1, 1996
Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levelsF Espana, I Zuazu, V Vicente, et al.Thrombosis and Haemostasis|June 28, 1990
Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatmentD Tabernero, F España, V Vicente, et al.Thrombosis Research|April 15, 1993
Repeated infusions of DDAVP induce low response of FVIII and vWF but not of plasminogen activatorsV Vicente, A Estellés, J Laso, et al.Thrombosis Research|June 1, 1992
Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic statesF España, J Gilabert, V Vicente, et al.Thrombosis Research|July 1, 1995
Activation of the protein C pathway in acute sepsisA Alcaraz, F España, J Sánchez-Cuenca, et al.Blood|July 15, 1991
Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted feverV Vicente, F España, D Tabernero, et al.Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1980
The congenital factor VII abnormalities (dysproconvertinemias). The genetic plot thickensA GirolamiArchivos Del Instituto De Cardiologia De Mexico|July 10, 1998
Low molecular weight heparins in clinical practice: unsolved or partially solved problemsA GirolamiFolia Haematologica (Leipzig, Germany : 1928)|January 1, 1987
A tentative classification of AT III congenital abnormalitiesA GirolamiClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 8, 2001
Idiopathic deep vein thrombosis and subsequent cancer: suggestions for a patient-oriented and practical approachA GirolamiPageof 103